India is participating in the NeoSep1 clinical trial, which aims to improve treatment for drug-resistant newborn sepsis using ...

Jipmer becomes the first Indian center to enroll an infant in the NeoSep1 trial, targeting neonatal sepsis and antimicrobial resistance.

India has enrolled its first newborn in the global NeoSep1 trial at JIPMER, Puducherry. The study will test antibiotic ...

The Global Antibiotic Research and Development Partnership (GARDP) said yesterday that an international clinical trial ...

Explore how predictive maternal healthcare, powered by AI and supported by public health teams, can enhance outcomes and save ...

Systemic inequality, malnutrition, and vaccination dropout rates are driving a rise in childhood infectious diseases across ...

A flu outbreak at Joint Base San Antonio Lackland Air Force Base has risen to 275 confirmed cases, up from 222 earlier in the ...

Pediatric hospital medicine is rapidly advancing with new research focusing on clinical management, quality improvement, health equity, and technology. This summary highlights the top articles from ...

Neonatal sepsis is a leading cause of infant morbidity and mortality in low- and middle-income countries (LMICs), yet despite this, progress in the development and implementation of effective ...

There are 12 childhood vaccines in wide use in South Africa. This guide unpacks what you need to know about each of them.South Africa provides routine vaccination against polio, tuberculosis, measles, ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...